arrow
Å

Åke Lernmark

lund university clinical research center
H指数:101
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dietary vitamin C intake and the risk of islet autoimmunity and type 1 diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY) Study

膳食维生素C摄入与胰岛自身免疫和1型糖尿病风险:青年糖尿病环境决定因素(TEDDY)研究

2026-09-240
OAAI
Quantitative temporal analysis of pancreatic islet T lymphocyte and macrophage infiltration heralded by serum IgE in congenic BioBreeding (BB) Gimap5−/− rats at risk for insulitis and acute onset diabetes

同系BioBreeding (BB) Gimap5−/−大鼠发生胰岛炎和急性发作糖尿病风险下,血清IgE预示的胰腺胰岛T淋巴细胞和巨噬细胞浸润的定量时间分析

2025-10-030
OA
Correction: Profiling associations of interactive ligand–receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants

更正:分析交互配体-受体(HLA class I和KIR基因产物)的表型特征及其与血清学转阳参与者进展至1型糖尿病的相关性

2025-09-270
OAAI
Profiling associations of interactive ligand–receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants

分析交互配体-受体(HLA class I和KIR基因产物)与血清转换参与者中1型糖尿病进展的关联性

2025-08-210
OAAI
The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum

1型糖尿病的异质性:对发病机制、预防和治疗的启示—2024年糖尿病、糖尿病护理和糖尿病学专家论坛

2025-07-300
OAAI
Predictors of Transitions From GADA as the Initial Autoantibody to Multiple Autoantibodies of Type 1 Diabetes in Children at Risk by a Dynamic Prediction Model

儿童高风险人群中从作为初始自身抗体的GADA到1型糖尿病多种自身抗体的转变预测因子:基于动态预测模型的研究

2025-01-010
OAAI
Looking back at the TEDDY study: lessons and future directions

回顾TEDDY研究: 经验教训和未来方向

2024-11-040
PRE
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers

在DPT-1和TN07临床试验中进展为1型糖尿病与HLA-DQA1-B1异二聚体中的特定残基密切相关

2024-10-010
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes ( vol 47, pg 1276, 2024)

监测胰岛自身抗体阳性前期3型糖尿病患者的共识指南 (第47卷,1276页,2024)

2024-09-060
PRE
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes (JUN, 10.1007/s00125-024-06205-5, 2024)

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南 (JUN,10.1007/s00125-024-06205-5,2024)

2024-09-040
OAAI
Early Appearance of Thyroid Autoimmunity in Children Followed From Birth for Type 1 Diabetes Risk

儿童甲状腺自身免疫的早期出现,从出生开始就有1型糖尿病的风险

2024-07-121
OA
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)

在TrialNet口服胰岛素预防试验 (TN07) 的HLA DR4-DQ8参与者中重新研究了3期1型糖尿病的口服胰岛素延迟

2024-07-011
PRE
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-243
OAAI
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes

监测胰岛自身抗体阳性的3期1型糖尿病患者的共识指南

2024-06-248
OA
Vitamin D Intake and Risk of Islet Autoimmunity (IA) and Type 1 Diabetes (T1D)
2024-06-140
PRE